$44,093,195
Department of Health and Human Services·National Institutes of Health
WORK BEGAN2022-05-01·LATEST ACTION2026-04-27·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N91022C00013_7529_-NONE-_-NONE-
Award description
CLINICAL TRIALS MONITORING SERVICE
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
The Buildout's read
What the model surfaced from this award
Confidence: high
In plain English
April 2026 obligation on the NIH's clinical trials monitoring contract, initiated in 2022.
Sub-sectors
clinical-trialsnih-fundeddrug-development-infrastructure
Why this matters
Clinical trial monitoring ensures patient safety and regulatory compliance in federally-funded drug development research.
Supply-chain signal
THERADEX supplies monitoring infrastructure essential to pharma companies and research institutions conducting federal trials.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-12. Cost: $0.024448.
Period of performance
Start
2022-05-01
End
2027-04-30
Status
activein 290 days
Sources
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75N91022C00013_7529_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.